Meet Our Audience

In-House Counsel 

In an increasingly dynamic and uncertain life science legal landscape, we recognise the practical challenges associated with monitoring frequent changes to judicial practises, regulations, laws and standards, both within and between jurisdictions.

The Life Science Legal Strategy Summit addresses this directly by offering in-house legal professionals the unique and exclusive opportunity to:

• Gain high-level insights from industry thought-leaders;
• Benchmark legal strategies through dedicated networking and roundtable discussion sessions; and
• Sharpen holistic understanding of key trends and challenges across in-house legal practices.

 

Law Firm & Consultants

The Life Science Legal Strategy Summit is the premier event for private practice lawyers and consultants specialising in topics ranging from IP prosecution, patent litigation and SPCs to competition, transactions and regulation.

LSLS 2026 offers law firms and consultants the vital opportunity to stand out in a competitive market by providing a dedicated forum for both forging and building meaningful client relationships. We provide attending firms with the unparalleled opportunity to:

• Network amongst an audience comprising over 50% in-house counsel;
• Showcase breadth of thought leadership across the legal strategy spectrum;
• Demonstrate deep-industry expertise in the topic areas aligned most intimately with their practice; and
• Build an enhanced, up-to-date understanding of the most pertinent issues at the interface between facets of life science legal strategy.

 

Service Providers

Standing out within a crowded market as a leading provider of legal and/or financial solutions for the life sciences is difficult. To that end, we encourage companies offering innovative platforms to solve the biggest legal strategy conundrums facing the pharmaceutical and biotechnology industries to join us at LSLS 2026.

This flagship conference offer vendors and solution providers the opportunity to:

• Establish meaningful connections with influential in-house and private practice decision-makers;
• Strengthen brand visibility and specific industry expertise through participating in panel discussions, sponsoring key sessions and engaging in interactive roundtable discussions;
• Maintain an up-to-date appreciation of the key problems facing life science legal teams; and
• Consolidate product portfolios to align precisely with current market challenges and demands.